Cytokeratin 7 抗体
-
- 抗原 See all Cytokeratin 7 (KRT7) 抗体
- Cytokeratin 7 (KRT7) (Keratin 7 (KRT7))
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This Cytokeratin 7 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC), Immunohistochemistry (Frozen Sections) (IHC (fro))
- 特异性
- Human exclusively.
- 纯化方法
- Purified
- 免疫原
- OVTL12/30 is a mouse monoclonal IgG1/kappa antibody derived by fusion of SP2/0-Ag14 mouse myeloma cells with spleen cells from a mouse immunized with a cytoskeletal preparation of OTN-11 ovarian carcinoma cell line.
- 克隆位点
- OVTL12-30
- 亚型
- IgG1
- Top Product
- Discover our top product KRT7 Primary Antibody
-
-
- 应用备注
- OVTL12/30 reacts exlcusively with cytokeratin 7 which is present in specific glandular-type epithelia and most carcinomas derived thereof. OVTL12/30 is effective on frozen tissue after fixation in methanol. It is particularly effective on paraffin-embedded tissue, for which pretreatment with e.g. 0.1% pronase / 0.1% trypsine in PBS or 0.5% pepsine in 0.01N HCl or microwave pretreatment is required. In addition, OVTL 12/30 is suitable for immunocytochemistry, immunoblotting and flow cytometry. Optimal antibody dilution should be determined by titration, recommended range is 1:100 - 1:200 for flow cytometry, and for immunohistochemistry with avidin-biotinylated horseradish peroxidase complex (ABC) as detection reagent, and 1:100 - 1:1000 for immunoblotting applications.
- 限制
- 仅限研究用
-
- 储存条件
- 4 °C
-
-
Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma." in: Histopathology, Vol. 32, Issue 1, pp. 20-7, (1998) (PubMed).
: "Differentiation margins of ovarian tumor pathology: first incidences of epithelial ovarian tumors monitored by marker antibodies." in: Cancer detection and prevention, Vol. 21, Issue 3, pp. 247-57, (1997) (PubMed).
: "OV-TL 12/30 (keratin 7 antibody) is a marker of glandular differentiation in lung cancer." in: Histopathology, Vol. 22, Issue 1, pp. 35-8, (1993) (PubMed).
: "Immunohistochemical demonstration of keratin 7 in routinely fixed paraffin-embedded human tissues." in: The Journal of pathology, Vol. 165, Issue 2, pp. 145-52, (1992) (PubMed).
: "Marker profile of different phases in the transition of normal human ovarian epithelium to ovarian carcinomas." in: The American journal of pathology, Vol. 138, Issue 2, pp. 455-63, (1991) (PubMed).
: "Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas." in: The American journal of pathology, Vol. 136, Issue 3, pp. 641-55, (1990) (PubMed).
: "
-
Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma." in: Histopathology, Vol. 32, Issue 1, pp. 20-7, (1998) (PubMed).
-
- 抗原
- Cytokeratin 7 (KRT7) (Keratin 7 (KRT7))
- 别名
- Cytokeratin 7 / Keratin K7 (KRT7 产品)
- 背景
- Cytokeratins are a subfamily of intermediate filament proteins and are characterized by a remarkable biochemical diversity, represented in human epithelial tissues by at least 20 different polypeptides. They range in molecular weight between 40 kDa and 68 kDa and isoelectric pH between 4.9 - 7.8. The individual human cytokeratins are numbered 1 to 20. The various epithelia in the human body usually express cytokeratins which are not only characteristic of the type of epithelium, but also related to the degree of maturation or differentiation within an epithelium. Cytokeratin subtype expression patterns are used to an increasing extent in the distinction of different types of epithelial malignancies. The cytokeratin antibodies are not only of assistance in the differential diagnosis of tumors using immunohistochemistry on tissue sections, but are also a useful tool in cytopathology and flow cytometric assays.
-